FDA Inspection 1218760 — Sparsh Hospital & Critical Care (P) Ltd
The FDA completed an inspection of Sparsh Hospital & Critical Care (P) Ltd on August 24, 2023 in Bhubaneswar. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 24, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bhubaneswar (India)
Additional Details
Clinical BA/BE